PCM
DGX icon

Penserra Capital Management’s Quest Diagnostics DGX Stock Holding History

Penserra Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
9
-6,252
-100% -$1.23M ﹤0.01% 1071
2026
Q1 		$1.23M Buy
6,261
+6,255
+104,250% +$1.22M 0.01% 423
2025
Q4 		$1K Buy
+6
New +$1.09K ﹤0.01% 1015
2025
Q1 		– Sell
-283
Closed -$42K – 1071
2024
Q4 		$42K Buy
283
+274
+3,044% +$42.6K ﹤0.01% 951
2024
Q3 		$1K Buy
9
+3
+50% +$448 ﹤0.01% 1063
2024
Q2 		$1K Hold
6
– – ﹤0.01% 1217
2024
Q1 		$0 Sell
6
-512
-99% -$66.4K ﹤0.01% 1286
2023
Q4 		$70K Sell
518
-108
-17% -$14.2K ﹤0.01% 941
2023
Q3 		$75K Sell
626
-101
-14% -$13.5K ﹤0.01% 941
2023
Q2 		$101K Buy
727
+504
+226% +$69.5K ﹤0.01% 937
2023
Q1 		$30K Sell
223
-18,865
-99% -$2.7M ﹤0.01% 880
2022
Q4 		$2.98M Buy
+19,088
New +$2.74M 0.07% 278
2020
Q2 		– Sell
-975
Closed -$109K – 826
2020
Q1 		$109K Buy
975
+51
+6% +$5.28K 0.01% 546
2019
Q4 		$103K Buy
924
+198
+27% +$20.6K 0.01% 586
2019
Q3 		$77K Buy
726
+264
+57% +$27.1K 0.01% 590
2019
Q2 		$47K Buy
462
+18
+4% +$1.73K ﹤0.01% 598
2019
Q1 		$42K Buy
+444
New +$38.5K ﹤0.01% 553
2017
Q1 		– Sell
-282
Closed -$25K – 626
2016
Q4 		$25K Buy
282
+61
+28% +$5.26K ﹤0.01% 511
2016
Q3 		$18K Buy
221
+88
+66% +$7.39K ﹤0.01% 564
2016
Q2 		$11K Buy
133
+44
+49% +$3.35K ﹤0.01% 574
2016
Q1 		$6K Sell
89
-5
-5% -$335 ﹤0.01% 622
2015
Q4 		$7K Buy
+94
New +$6.32K ﹤0.01% 615

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Penserra Capital Management's DGX Position: Q2 2026 in Review

Penserra Capital Management reduced its Quest Diagnostics (DGX) stake by 100% in Q2 2026, selling an estimated $1.23M and leaving 9 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Penserra Capital Management first reported a position in DGX in Q4 2015 and has held it in 22 quarters since. The position peaked at $2.98M in Q4 2022. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Penserra Capital Management held 9 shares of Quest Diagnostics worth $1K as of Q2 2026.
  • Penserra Capital Management sold 6,252 Quest Diagnostics shares in Q2 2026, an estimated $1.23M.
  • Quest Diagnostics made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #1071 holding.
  • Penserra Capital Management first reported a position in Quest Diagnostics in Q4 2015 and has held it in 22 quarters since.
  • Penserra Capital Management's Quest Diagnostics position peaked at $2.98M in Q4 2022.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.